Navigation Links
BMP Sunstone Reports Second Quarter 2008 Financial Results
Date:8/11/2008

orized as of March 31, 2008 and

December 31, 2007, respectively;

39,492,026 and 31,240,913 Shares

Issued and Outstanding as of March 31,

2008 and December 31, 2007, respectively 40 31

Additional Paid in Capital 157,070 66,123

Common Stock Warrants 9,156 9,747

Accumulated Deficit (31,345) (27,600)

Accumulated Other Comprehensive

Income 8,561 708

Total Stockholders' Equity 143,482 49,009

Total Liabilities and Stockholders'

Equity $226,388 $80,923

Non GAAP Reconciliations

($ amounts, except per share amounts

in thousands)

Three Months Ended June 30,

2008 2007

GAAP Gross Profit $16,561 976

Amortization Related to Acquisition 107 --

Non GAAP Gross Profit $16,668 $976

Three Months Ended June 30,

2008 2007

GAAP Operating Income (Loss) $1,604 $(1,653)

Stock Based Compensation 616 356

Amortization Related to Acquisitions 992 64

Non GAAP Operating Income (Loss) $3,212 $(1,233)

Three Months Ended June 30,

2008 200
'/>"/>

SOURCE BMP Sunstone Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
2. BMP Sunstone Receives Import Drug License (IDL) from SFDA
3. BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial
4. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
5. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
6. Pharmos Corporation Reports 2008 Second Quarter Results
7. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
8. Par Pharmaceutical Reports Second Quarter 2008 Results
9. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
10. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
11. Isis Reports Financial Results and Highlights for Second Quarter of 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 VG ... strategic alliance with DAK Renewable Research to conduct ... oil yield. VG Energy is a majority owned ... VGLS). VG Energy,s exclusively licensed compound ... the oil yield in plants, possessing a wide ...
(Date:5/23/2013)... 23, 2013 Virobay, Inc. today announced that ... reached an important milestone, as Virobay has now initiated ... selective cathepsin S inhibitor.   The first ... placebo-controlled study designed to evaluate the safety, tolerability, pharmacokinetics ... adults. "The initiation of this Phase 1 ...
(Date:5/23/2013)... May 23, 2013 On April 19th ... to supermarkets to search for the growing antibiotic resistant ... Results from a year long study were released late ... foods, specifically meats, over previous years. For those suffering ... growth of antibiotic resistant bacteria in food, may eventually ...
(Date:5/23/2013)... Md. , May 23, 2013 Northwest ... biotechnology company developing DCVax ® personalized immune therapies ... use its exhibit at this year,s American Society Of ... to highlight its leadership role in immune therapy.  ... The ASCO annual meeting is the pre-eminent conference focused ...
Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3
... Equity Research, Inc.,(Scimitar) issues a review of Neurobiological ... Treatments, Look at One Stroke,Drug at a Time; ... available at our website: http://www.scimitarequity.com ., ... in the business of acquiring and developing central ...
... Feb. 14 BiPar Sciences, Inc., a,privately held ... Huh, M.D., Ph.D., has been appointed,President and Chief ... on,March 3, 2008., Dr. Huh previously served ... Business Unit at Nektar Therapeutics, a drug development ...
... 14 GeoPharma, Inc. (Nasdaq:,GORX) announced record revenues ... than a 200% increase in sales sequentially, as ... month periods ending,December 31, 2007., "We are ... the,third quarter of our 2008 fiscal year; it ...
Cached Biology Technology:Neurobiological Technologies, Inc. (Nasdaq: NTII) Q2/08 Review Issued By Scimitar Equity Research, Inc. 2BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer 2GeoPharma Announces Record Revenues in Third Quarter Results 2GeoPharma Announces Record Revenues in Third Quarter Results 3GeoPharma Announces Record Revenues in Third Quarter Results 4GeoPharma Announces Record Revenues in Third Quarter Results 5GeoPharma Announces Record Revenues in Third Quarter Results 6
(Date:5/23/2013)... at Rollins School of Public Health at Emory ... of Technology, have received a $4 million grant ... at Emory University (Health and Exposome Research Center: ... exposome-based center grant awarded in the United States. ... the National Institute of Environmental Health Sciences (NIEHS) ...
(Date:5/23/2013)... Given the implications for the overall health, ... play a primary role in ensuring that all ... 60 minutes per day of vigorous or moderate-intensity ... Institute of Medicine. Recent estimates suggest that ... evidence-based guideline for promoting better health and development. ...
(Date:5/23/2013)... in treating cerebral palsy with autologous cord blood. Following ... year old boy had been in a persistent vegetative ... months after treatment with the cord blood containing stem ... the child learned to speak simple sentences and to ... study, dispel the long-held doubts about the effectiveness of ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3First successful treatment of pediatric cerebral palsy with autologous cord blood 2
... VALLEY, Pa., June 1, 2009 Olympus America Inc. ... NIR, a biliary metallic stent designed with exceptional anatomic ... NIRflex cell design provides a physician support and flexibility; ... pancreatic, liver and bile duct cancers. ...
... how different species are likely to respond to climate ... a species and the interactions between species, in the ... of BioScience , by Eric Post of Pennsylvania ... can be avoided. Their approach, which relies on multi-stage ...
... our cells possess an internal clock, a group of genes ... a day. A large number of circadian genes are expressed ... be precisely regulated over the course of the day. A ... Research Frontiers in Genetics, based at the University of Geneva, ...
Cached Biology News:MicroRNAs grease the cell's circadian clockwork 2
... quick and easy operation of a wide ... The software is fully secure and ... Part 11 regulations, and compatible with user-created ... versatility enables use in high-level research and ...
... We can introduce random mutations to the ... be then cloned into a vector of choice ... Mutation frequency can be set to a ... Number of clones 106-108. Mutations can be ...
... The Freedom EVOlyzer is Tecans new Enzyme-Linked ... microplate processing. Freedom EVOlyzer is a dedicated ... state-of-the art reader, washer and incubation units ... The Freedom EVOlyzer is available in three ...
... The Digital Clamp One can operate as ... as a Conductance (Dynamic) Clamp in electrophysiology research ... as good as conventional analog equipment. This ... advances in the capabilities of Digital Signal Processing ...
Biology Products: